Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses

Annals of the New York Academy of Sciences

Volumn 840, Issue , 1998, Pages 540-550

  Goetzl, Edward J ^a,b   Pankhaniya, Ravi R ^a,c   Gaufo, Gary O ^a   Yajun, M U ^a   Xia, Menghang ^a   Sreedharan, Sunil P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MATRIX METALLOPROTEINASE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

B LYMPHOCYTE; BASEMENT MEMBRANE; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; INNERVATION; MACROPHAGE; MAST CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; T LYMPHOCYTE;

EID: 0032077519     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09593.x     Document Type: Conference Paper

References (64)

1. GOETZL, E. J. & S. P. SREEDHARAN. 1992. Mediators of communication and adaptation in the neuroendocrine and immune systems. FASEB J. 6: 2646-2652.
2. STEINMAN, L. 1993. Connections between the immune system and the nervous system. Proc. Natl. Acad. Sci. USA 90: 7912-7914.
3. LOTAN, M. & M. SCHWARTZ. 1994. Cross talk between the immune system and the nervous system in response to injury: Implications for regeneration. FASEB J. 8: 1026-1033.
4. MERRILL, J. E. & G. M. JONAKAIT. 1995. Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease. FASEB J. 9: 611-618.
5. FELTEN, D. L., S. Y. FELTEN, D. L. BELLINGER, S. L. CARLSON, K. D. ACKERMAN, K. S. MADDEN, J. A. OLSCHOWKA & S. LIVNAT. 1987. Noradrenergic sympathetic neural inter-actions with the immune system: Structure and function. Immunol. Rev. 100: 225-260.
6. FINK, T. & E. WEIHE. 1988. Multiple neuropeptides in nerves supplying mammalian lymph nodes: Messenger candidates for sensory and autonomie neuroimmunomodulation. Neurosci. Lett. 90: 39-54.
7. GOETZL, E. J., D. C. ADELMAN & S. P. SREEDHARAN. 1990. Neuroimmunology. Adv. Immunol. 48: 161-190.
8. PATTERSON, P. H. 1994. Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology. Proc. Natl. Acad. Sci. USA 91: 7833-7835.
9. BENVENISTE, E. N. & D. J. BENOS. 1995. TNF-α- and IFN-α-mediated signal transduction pathways: Effects on glial cell gene expression and function. FASEB J. 9: 1577-1584.
10. STEAD, R. H., M. TOMIOKA, G. QUINONEZ, G. T. SIMON, S. Y. FELTEN & J. BIENENSTOCK. 1987. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl. Acad. Sci. USA 84: 2975-2979.
11. FELTEN, S. Y. & J. A. OLSCHOWKA. 1987. Noradrenergic sympathetic innervation of the spleen. II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18: 37-48.
12. STANISZ, A. M., R. SCICCHITANO, P. DAZIN, J. BIENENSTOCK & D. G. PAYAN. 1987. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J. Immunol. 139: 749-754.
13. ICHIKAWA, S., S. P. SREEDHARAN, E. J. GOETZL & R. L. OWEN. 1994. Immunohistochemical localization of peptidergic nerve fibers and neuropeptide receptors in Peyer's patches of the cat ileum. Regul. Peptides 54: 385-395.
14. ICHIKAWA, S., S. P. SREEDHARAN, R. L. OWEN & E. J. GOETZL. 1995. Immunochemical localization of type IVIP receptor and NK-1-type substance P receptor in rat lung. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L584-L588.
15. DONNERER, J., A. EGLEZOS & R. D. HEMLE. 1991. Neuroendocrine and immune function in the capsaicin-treated rat: Evidence for afferent neural modulation in vivo. In The Neuroendocrine-Immune Network. S. Freier, Ed.: 70-85. CRC Press. Boca Raton, FL.
16. ACKERMAN, K. D., K. S. MADDEN, S. LIVNAT, S. Y. FELTEN & D. L. FELTEN. 1991. Neonatal sympathetic denervation alters the development of in vitro spleen cell proliferation and differentiation. Brain Behav. Immun. 5: 235-261.
17. WEIHE, E., D. HOHR & S. MICHAEL. 1991. Molecular anatomy of the neuroimmune connection. Int. J. Neurosci. 59: 1-23.
18. GOMARIZ, R. P., M. DELGADO, J. R. NARANJO, B. MELLSTROM, A. TORMO, F. MATA & J. LECETA. 1993. VIP gene expression in rat thymus and spleen. Brain Behav. Immun. 7: 271-278.
19. OTTAWAY, C. A. 1984. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J. Exp. Med. 160: 1054-1069.
20. OHKUBO, N., S. MIURA, H. SERIZAWA, H. J. YAN, H. KIMURA, H. IMAEDA, H. TASHIRO & M. TSUCHIYA. 1994. In vivo effect of chronic administration of vasoactive intestinal peptide on gut-associated lymphoid tissues in rats. Regul. Peptides. 50: 127-135.
21. OTTAWAY, C. A. 1991. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol. Clin. N. Am. 20: 511-529.
22. BARNES, P. J., J. N. BARANIUK & M. G. BELVISI. 1991. Neuropeptides in the respiratory tract. Part I. Am. Rev. Resp. Dis. 144: 1187-1198.
23. LUTS, A., R. UDDMAN, P. ALM, J. BASTERRA & F. SUNDLER. 1993. Peptide-containing nerve fibers in human airways: Distribution and coexistence pattern. Int. Arch. Allergy Immunol. 101: 52-60.
24. SAID, S. 1994. Vasoactive intestinal polypeptide in the respiratory tract. Ju Neuropeptides in Respiratory Medicine. M. A. Kaliner, P. J. Barnes, G. H. H. Kunkel & J. N Baraniuk, Eds.: 143-160. Marcel Dekker Press. New York.
25. KATO, I., Y. SUZUKI, A. AKABANE, H. YONEKURA, O. TANAKA, H. KONDO, S. TAKASAWA, T. YOSHIMOTO & H. OKAMOTO. 1994. Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic beta cells. Evidence for improved glucose tolerance and enhanced insulin secretion by VIP and PHM-27 in vivo. J. Biol. Chem. 269: 21223-21228.
26. WALKER, K. B., M. H. SERWONSKA, F. H. VALONE, W. S. HARKONEN, O. L. FRICK, K. H. SCRIVEN, W. D. RATNOFF, J. G. BROWNING, D. G.PAYAN & E. J. GOETZL. 1990. Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen. J. Clin. Immunol. 8: 108-113.
27. MOSLMANN, B. L., M. V. WHITE, R. J. HORMAN, M. S. GOLDRICH, H. C. KAULBACH & M. A. KALINER. 1993. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J. Allergy Clin. Immunol. 92: 95-104.
28. NIEBER, K., C. R. BAUMGARTEN, R. RATHSACK, J. FURKERT, P. OEHME & G. KUNKEL. 1992. Substance P and beta-endorphin-like immunoreactivity in lavage fluid of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 90: 646-654.
29. GOETZL, E. J., S. P. SREEDHARAN & H. B. KALTREIDER. 1994. Neuroregulation of pulmonary immunity: The roles of substance P and vasoactive intestinal peptide. In Neuropeptides in Respiratory Medicine. M. A. Kaliner, P. J. Barnes, G. H. H. Kunkel & J. N. Baraniuk, Eds.: 607-616. Marcel Dekker. New York.
30. GOETZL, E. J., S. ICHIKAWA, D. A. INGRAM, J. L. KISHIYAMA, M. XIA, S. P. SREEDHARAN, P. K. BYRD & H. B. KALTREIDER. 1995. Neuropeptide regulation of pulmonary parenchymal immune responses. In Proceedings of the XVI European Congress of Allergology and Clinical Immunology. A. Basomba & J. Sastre, Eds.: 161-167. Monduzzi Editore. Bologna.
31. KALTREIDER, H. B., S. ICHIKAWA, P. K. BYRD, D. A. INGRAM, J. L. KISHIYAMA, S. P. SREEDHARAN, M. L. WARNOCK, J. M. BECK & E. J. GOETZL. 1997. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am. J. Resp. Cell. Mol. Biol. 16: 133-144.
32. WALLENGREN, J., H. MOLLER & R. EKMAN. 1987. Occurrence of substance P, vasoactive intestinal peptide, and calcitonin gene-related peptide in dermographism and cold urticaria. Arch. Dermatol. Forsch. 279: 512-515.
33. TOBIN, D., G. NABARRO, H. BAART DE LA FAILLE, W. A. VAN VLOTEN, S. C. VAN DER PUTTE & H. J. SCHUURMAN. 1992. Increased number of immunoreactive nerve fibers in atopic dermatitis. J. Allergy Clin. Immunol. 90: 613-622.
34. NAKANISHI, S. 1991. Mammalian tachykinin receptors. Annu. Rev. Neurosci. 14: 123-136.
35. ISHIHARA, T., R. SHIGEMOTO, K. MORI, K. TAKAHASHI & S. NAGATA. 1992. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8: 811-819.
36. SREEDHARAN, S. P., J-X. HUANG, M. C. CHEUNG & E. J. GOETZL. 1995. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Natl. Acad. Sci. USA 92: 2939-2943.
37. LUTZ, E. M., W. J. SHEWARD, K. M. WEST, J. A. MORROW, G. A. FLNK & J. HARMAR. 1993. The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEES Lett. 334: 3-8.
38. 2+ and cAMP signals. J. Clin. Immunol. 16:21-30.
39. XIA, M., S. P. SREEDHARAN, D. R. BOLIN, G. O. GAUFO & E. J. GOETZL. 1997. A novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. J. Pharmacol. Exp. Ther. In press.
40. MCCORMACK, R. J., R. P. HART & D. GANEA. 1996. Expression of NK-1 receptor mRNA in murine lymphocytes. Neuroimmunomodulation 3: 35-46.
41. LITWIN, D. K., A. K. WILSOM & S. I. SAID. 1992. Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro. Regul. Peptides 40: 63-74.
42. SAKAKIBARA, H., K. SHIMA & S. I. SAID. 1994. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Am. J. Physiol. 267: L256-L262.
43. METWALI, A., D. ELLIOTT, A. M. BLUM, J. LI, M. SANDOR & J. V. WEINSTOCK. 1996. T cell vasoactive intestinal peptide receptor subtype expression differs between granulomas and spleen of Schistosome-infected mice. J. Immunol. 157: 265-270.
44. ROY CHOUDHURY, A., E. J, GOETZL, M. XIA, S. P. SREEDHARAN, G. T. FURUTA, C. MORYSWORTMANN, S. J. GALLI, W. E. SCHMIDT & B. K.WERSHIL. 1997. Mouse mast cells grown in stem cell factor express only type I vasoactive intestinal peptide. J. Clin. Invest. In press.
45. GOETZL, E. J., G. GAUFO, S. P. SREEDHARAN & M. XIA. 1996. Transduction of specific inhibition of HuT78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors. J. Immunol. 157: 1132-1138.
46. Bozic, C. R., B. Lu, U. E. HOPKEN, C. GERARD & N. P. GERARD. 1996. Neurogenic amplification of immune complex inflammation. Science 273: 1722-1725.
47. SAID, S. I., H. I. BERISHA & H. PAKBAZ. 1996. Excitotoxicity in the lung: N-methyl-D-aspartate-induced, NO-dependent pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase. Proc. Nail. Acad. Sci. USA 93: 4688-4692.
48. PIEDIMONTE, G. 1995. Tachykinin peptides, receptors, and peptidases in airway disease. Exp. Lung Res. 21: 809-834.
49. JOHNSTON, J. A., D. D. TAUB, A. R. LLOYD, K. CONLON, J. J. OPPENHEIM & D. J. KEVUN. 1994. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J. Immunol. 153: 1762-1768.
50. XIA, M., D. LEPPERT, S. L. HAUSER, S. P. SREEDHARAN, P. J. NELSON, A. M. KRENSKY & E. J. GOETZL. 1996. Stimulus-specificity of matrix metalloproteinase-dependence of human T cell migration through a model basement membrane. J. Immunol. 156: 160-167.
51. XIA, M., S. P. SREEDHARAN, P. DAZIN, C. H. DAMSKY & E. J. GOETZL. 1996. Integrin-dependent induction of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane. J. Cell Biochem. 61: 452-458.
52. GANEA, D. & L. SUN. 1993. VIP downregulates the expression of IL-2 but not of IFN-y from stimulated murine T lymphocytes. J. Neuroimmunol. 47: 147-155.
53. SUN, L. & D. GANEA. 1993. VIP inhibits IL-2 and IL-4 production through different mechanisms in T cells activated via the TCR/CD3 complex. J. Neuroimmunol. 48: 59-66.
54. MATHEW, R. C., G. A. COOK, A. M. BLUM, A. METWALI, R. FELMAN & J. V. WEINSTOCK. 1992. VIP stimulates T lymphocytes to release IL-5 in murine Schistosomiasis mansoni infection. J. Immunol. 148: 3572-3580.
55. HASSNER, A., M. S. LAU, E. J. GOETZL & D. C. ADELMAN. 1993. Isotype-specific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide. J. Allergy Clin. Immunol. 92: 891-901.
56. BOIRIVANT, M., S. FAIS, B. ANNIBALE, D. AGOSTINI, G. DELLE FAVE & F. PALLONE. 1994. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology 106: 576-582.
57. FUJIEDA, S., J. A. WASCHER, K. ZHANG & A. SAXON. Vasoactive intestinal peptide induces Salpha/Smu switch circular DNA in human B cells. J. Clin. Invest. In press.
58. TAYLOR, A. W., J. W. STREILEIN & S. W. COUSINS. 1994. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153: 1080-1086.
59. FERGUSON, T. A., S. FLETCHER, J. HERNDON & T. S. GRIFFITH. 1995. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J. Immunol. 155: 1746-1756.
60. SMITH, C. H., J. N. BARKER, R. W. MORRIS, D. M. MACDONALD & T. H. LEE. 1993. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J. Immunol. 151: 3274-3282.
61. ROMANIC, A. M. & J. A MADRI. 1994. The induction of 72-kDa gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125: 1165-1178.
62. ROBICHON, A., S. P. SREEDHARAN, J. YANG, R. S. SHAMES, E. C. GRONROOS, P. P-J. CHENG & E. J. GOETZL. 1993. Induction of aggregation of Raji human B-lymphoblastic cells by vasoactive intestinal peptide. Immunology 79: 574-579.
63. PANKHANIYA, R. R., T. A. YEDNOCK, P. F. DAZIN & E. J. GOETZL. 1997. Induction of the high-affinity conformation of α4 β1 integrin on human T cells by vasoactive intestinal peptide. FASEB J. In press.
64. YEDNOCK, T. A., C. CANNON, C. VANDERVERT, E. G. GOLDBACH, G. SHAW, D. K. ELLIS, C. LIAW, L. C. FRITZ & L. I. TANNER. 1995. α4 β1 Integrin-dependent cell adhesion is regulated by a low-affinity receptor pool that is conformationally responsive to ligand. J. Biol. Chem. 270: 28740-28750.